{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/bone-soft-tissue-sarcoma-recognition-referral/management/referral-for-suspected-bone-soft-tissue-sarcoma-in-adults/","result":{"pageContext":{"chapter":{"id":"9db4d7e1-010f-5499-ae69-91208825f7b3","slug":"referral-for-suspected-bone-soft-tissue-sarcoma-in-adults","fullItemName":"Scenario: Referral for suspected bone and soft tissue sarcoma in adults","depth":2,"htmlHeader":"<!-- begin field 45c94be7-3cef-41dd-9887-0c50b2fd837a --><h2>Scenario: Referral for suspected bone and soft tissue sarcoma in adults</h2><!-- end field 45c94be7-3cef-41dd-9887-0c50b2fd837a -->","summary":"Covers the referral of adults with suspected bone or soft tissue sarcoma.","htmlStringContent":"<!-- begin item 298e9d94-debc-4f31-baea-1c97f84f8cdb --><!-- begin field 68635d68-231c-4cf6-936d-acd900acbdb8 --><p>From age 16 years onwards.</p><!-- end field 68635d68-231c-4cf6-936d-acd900acbdb8 --><!-- end item 298e9d94-debc-4f31-baea-1c97f84f8cdb -->","topic":{"id":"e4747ecc-d17a-5e2c-bd0c-69fc109a74f5","topicId":"6f65762b-a612-4ce9-80e5-ee8cb24f6dde","topicName":"Bone and soft tissue sarcoma - recognition and referral","slug":"bone-soft-tissue-sarcoma-recognition-referral","lastRevised":"Last revised in August 2020","chapters":[{"id":"edf8fdb6-68e6-5dac-916a-206d3893e4b8","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"0b6c5a9d-30a1-51f3-b16c-afbf78f00757","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"f18ae9ed-24b3-5a8f-b9fa-aabc10e5ced7","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"25f4d7d5-200e-50b1-b791-8478134bfee4","slug":"changes","fullItemName":"Changes"},{"id":"cee3f7fc-90f5-5bab-8b99-9ad854a538e7","slug":"update","fullItemName":"Update"}]},{"id":"69a11364-50c2-5893-ba48-bfc291fd9678","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"5941fcea-4bbf-5dbd-9c8b-4fffe5ff513c","slug":"goals","fullItemName":"Goals"},{"id":"82675336-6e84-5f8b-8ae2-b134dad3713d","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"04ecd3ef-a02c-5cfe-857c-97bed1748869","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"19da7d85-1a17-5d25-99b1-16680fb8dad5","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"e7f50592-c92d-57c3-8c6a-cfe55345fd8f","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"009b5c07-0fe5-557c-8a45-c7108109e1b5","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"c03fa4ab-14ef-53f1-9ac4-1e56c50d705d","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"a27bf635-6878-5608-8d61-f30c114978f7","slug":"presentation","fullItemName":"Presentation"},{"id":"62b4b53a-17f2-5696-98a7-4e7f3c9c3de7","slug":"prevalence","fullItemName":"Prevalence"},{"id":"358d5300-5ab8-55bc-859a-9942fc31c4e2","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"ddf19e0c-fe9b-5f6c-afc9-9a4dd392dbc2","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"1f947dbd-c647-5adb-9201-f12c1c87035d","slug":"symptoms-suggestive-of-bone-soft-tissue-sarcoma","fullItemName":"Symptoms suggestive of  bone and soft tissue sarcoma"},{"id":"6862abd5-4206-520f-84ce-551b9804968c","slug":"primary-care-investigations-for-bone-soft-tissue-sarcoma","fullItemName":"Primary care investigations for bone and soft tissue sarcoma"}]},{"id":"110de2f9-5daa-5079-a41a-f825ae71373b","fullItemName":"Management","slug":"management","subChapters":[{"id":"9db4d7e1-010f-5499-ae69-91208825f7b3","slug":"referral-for-suspected-bone-soft-tissue-sarcoma-in-adults","fullItemName":"Scenario: Referral for suspected bone and soft tissue sarcoma in adults"},{"id":"0c156dc0-c7e2-5e4c-9dab-dc5aeff6db66","slug":"referral-for-suspected-bone-soft-tissue-sarcoma-in-children-young-people","fullItemName":"Scenario: Referral for suspected bone and soft tissue sarcoma in children and young people"}]},{"id":"a613a902-9172-5bf6-96a1-8005ef1e1891","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"849285c0-c49a-5974-b160-a00c41b27871","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"6d6ae6fc-a667-541c-95fe-a5a702055efb","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"2abec814-d80c-5b2b-8a04-3b8ffbfa5fe7","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"7c763a93-7e4c-5cd8-bcd6-5b896bfbba34","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"10b065a8-9445-5a79-8d56-0772ea690539","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"7b6299b1-4f46-5e17-96aa-6b432b5d3dd3","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"1ed23bde-0b8f-50fb-b4c1-08008605ca0b","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"110de2f9-5daa-5079-a41a-f825ae71373b","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"61a5b19f-0b47-5509-91dc-744587e6cf69","slug":"referral-timelines","fullItemName":"Referral timelines","depth":3,"htmlHeader":"<!-- begin field 31c54d0e-1160-4185-bfc6-387574d0a717 --><h3>Referral timelines</h3><!-- end field 31c54d0e-1160-4185-bfc6-387574d0a717 -->","summary":null,"htmlStringContent":"<!-- begin item 33aa9986-9014-4d06-9c8b-332d290e9e6a --><!-- begin field 6f1c0796-c17d-4298-8b66-401e0ad1555a --><ul><li>The terms used in the National Institute for Health and Care Excellence (NICE) guideline <em>Suspected cancer: recognition and referral</em> are as follows:<ul><li>Immediate: an acute admission or referral occurring within a few hours, or even more quickly if necessary.</li><li>Urgent: to happen/be performed within 2 weeks.</li><li>Very urgent: to happen within 48 hours.</li><li>Non-urgent: the timescale generally used for a referral or investigation that is not considered very urgent or urgent.</li><li>Suspected cancer pathway referral: the patient is seen within the national target for cancer referrals (2 weeks at the time of publication of the 2015 NICE guideline <em>Suspected cancer: recognition and referral</em>).</li></ul></li></ul><!-- end field 6f1c0796-c17d-4298-8b66-401e0ad1555a --><!-- end item 33aa9986-9014-4d06-9c8b-332d290e9e6a -->","subChapters":[{"id":"bef00534-d8e3-5207-910e-2cdce47b4b06","slug":"basis-for-recommendation-28c","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field f58edbbb-3058-4465-924d-21f3b8040c17 --><h4>Basis for recommendation</h4><!-- end field f58edbbb-3058-4465-924d-21f3b8040c17 -->","summary":null,"htmlStringContent":"<!-- begin item 28c41953-6e33-4a85-b546-03e0e31d402a --><!-- begin field 1468535c-1e05-4f5a-841c-3dd46c2b7700 --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/bone-soft-tissue-sarcoma-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 1468535c-1e05-4f5a-841c-3dd46c2b7700 --><!-- end item 28c41953-6e33-4a85-b546-03e0e31d402a -->","subChapters":[]}]},{"id":"9b34a7fe-d830-5dc6-81e1-3054a16a32ce","slug":"referral-for-suspected-bone-sarcoma","fullItemName":"Referral for suspected bone sarcoma","depth":3,"htmlHeader":"<!-- begin field 76186096-8755-4de9-adf8-2d1d55468440 --><h3>When should I refer an adult with suspected bone sarcoma?</h3><!-- end field 76186096-8755-4de9-adf8-2d1d55468440 -->","summary":null,"htmlStringContent":"<!-- begin item ff5a965e-f128-44f4-bea5-95787d3d8dad --><!-- begin field 992cc6b3-0872-4581-95f8-36cc25127306 --><ul><li><strong>Consider a suspected cancer pathway referral,</strong> for an appointment within 2 weeks, for adults if an X-ray suggests the possibility of bone sarcoma (new NICE recommendation for 2015).<ul><li>Separate recommendations have been made for adults and for children and young people to reflect that there are different referral pathways. However, in practice young people (aged 16–24 years) may be referred using either an adult or children's pathway depending on their age and local arrangements.</li></ul></li></ul><!-- end field 992cc6b3-0872-4581-95f8-36cc25127306 --><!-- end item ff5a965e-f128-44f4-bea5-95787d3d8dad -->","subChapters":[{"id":"33d8d31a-fbdd-51de-bdd1-02e1a6d4df73","slug":"basis-for-recommendation-537","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 1c93642d-1743-4f16-a491-a2b728fdf066 --><h4>Basis for recommendation</h4><!-- end field 1c93642d-1743-4f16-a491-a2b728fdf066 -->","summary":null,"htmlStringContent":"<!-- begin item 537fd882-d3d9-44cb-9966-180747a021ab --><!-- begin field b972b4cb-68d7-4eb5-96af-1c417d7d612c --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/bone-soft-tissue-sarcoma-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field b972b4cb-68d7-4eb5-96af-1c417d7d612c --><!-- end item 537fd882-d3d9-44cb-9966-180747a021ab -->","subChapters":[]}]},{"id":"7681a33b-60ec-567e-b125-96cbb83888cc","slug":"referral-for-suspected-soft-tissue-sarcoma","fullItemName":"Referral for suspected soft tissue sarcoma","depth":3,"htmlHeader":"<!-- begin field 3e44849f-6647-40b0-85ac-817a69475ce9 --><h3>When should I refer an adult with suspected soft tissue sarcoma?</h3><!-- end field 3e44849f-6647-40b0-85ac-817a69475ce9 -->","summary":null,"htmlStringContent":"<!-- begin item b949489f-aba7-4e1d-8f34-79874551855c --><!-- begin field 92185816-7b73-4ed5-8f9c-9654bcbcc928 --><ul><li><strong>Consider an urgent direct access ultrasound scan,</strong> to be performed within 2 weeks, to assess for soft tissue sarcoma in adults with an unexplained lump that is increasing in size (new NICE recommendation for 2015).</li><li><strong>Consider a suspected cancer pathway referral,</strong> for an appointment within 2 weeks, for adults if they have ultrasound scan findings that are suggestive of soft tissue sarcoma OR if ultrasound findings are uncertain and clinical concern persists (new NICE recommendation for 2015).</li><li>Separate recommendations have been made for adults and for children and young people to reflect that there are different referral pathways. However, in practice young people (aged 16–24 years) may be referred using either an adult or children's pathway depending on their age and local arrangements.</li></ul><!-- end field 92185816-7b73-4ed5-8f9c-9654bcbcc928 --><!-- end item b949489f-aba7-4e1d-8f34-79874551855c -->","subChapters":[{"id":"f8b05d27-afaa-53aa-b189-074445e78e08","slug":"basis-for-recommendation-a68","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 0564b633-d9c1-4358-bfe1-8f221f07756c --><h4>Basis for recommendation</h4><!-- end field 0564b633-d9c1-4358-bfe1-8f221f07756c -->","summary":null,"htmlStringContent":"<!-- begin item a68ee782-e3a3-4557-ae1d-65d9b505095b --><!-- begin field 797387bc-9683-4c1e-a1d1-c37347044baf --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/bone-soft-tissue-sarcoma-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 797387bc-9683-4c1e-a1d1-c37347044baf --><!-- end item a68ee782-e3a3-4557-ae1d-65d9b505095b -->","subChapters":[]}]},{"id":"000db239-63c4-54a3-bbe1-185afdaa3acd","slug":"diagnostic-referral-process","fullItemName":"Diagnostic and referral process","depth":3,"htmlHeader":"<!-- begin field 2c41e6c2-802a-46e2-9d7d-ae2281fef96f --><h3>Diagnostic and referral process</h3><!-- end field 2c41e6c2-802a-46e2-9d7d-ae2281fef96f -->","summary":null,"htmlStringContent":"<!-- begin item ad7a968c-f2d1-4226-8d9b-dbe246644b8c --><!-- begin field ad0f4daf-3897-4cd4-a763-6f795c0f7732 --><ul><li>Discussion with a specialist (for example, by telephone or email) should be considered if there is uncertainty about the interpretation of symptoms and signs, and whether a referral is needed. This may also enable the primary healthcare professional to communicate their concerns and a sense of urgency to secondary healthcare professionals when symptoms are not classical.</li><li>Put in place local arrangements to ensure that letters about non-urgent referrals are assessed by the specialist, so that the person can be seen more urgently if necessary.</li><li>Put in place local arrangements to ensure that there is a maximum waiting period for non-urgent referrals, in accordance with national targets and local arrangements.</li><li>Ensure local arrangements are in place to identify people who miss their appointments so that they can be followed up.</li><li>Include all appropriate information in referral correspondence, including whether the referral is urgent or non-urgent.</li><li>Use local referral proformas if these are in use.</li><li>Once the decision to refer has been made, make sure that the referral is made within 1 working day.</li><li>Take part in continuing education, peer review, and other activities to improve and maintain clinical consulting, reasoning, and diagnostic skills, in order to identify at an early stage people who may have cancer, and to communicate the possibility of cancer to the person.</li></ul><!-- end field ad0f4daf-3897-4cd4-a763-6f795c0f7732 --><!-- end item ad7a968c-f2d1-4226-8d9b-dbe246644b8c -->","subChapters":[{"id":"959ecad5-aaf4-5fa6-a024-dc9a8c00bb81","slug":"basis-for-recommendation-4f3","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 7fdf138d-877e-402c-b651-1e30f13db2a4 --><h4>Basis for recommendation</h4><!-- end field 7fdf138d-877e-402c-b651-1e30f13db2a4 -->","summary":null,"htmlStringContent":"<!-- begin item 4f37ecdd-383a-4d36-82fd-e3b5069833fa --><!-- begin field 334818c0-9836-4b24-ac20-677b2936a6bd --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/bone-soft-tissue-sarcoma-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 334818c0-9836-4b24-ac20-677b2936a6bd --><!-- end item 4f37ecdd-383a-4d36-82fd-e3b5069833fa -->","subChapters":[]}]},{"id":"279c6c3a-2edc-5257-8652-6fff809c4cb2","slug":"patient-information-support","fullItemName":"Patient information and support","depth":3,"htmlHeader":"<!-- begin field f53b35d4-c0e5-4798-97dc-3812ef174569 --><h3>What patient information and support should I offer?</h3><!-- end field f53b35d4-c0e5-4798-97dc-3812ef174569 -->","summary":null,"htmlStringContent":"<!-- begin item 34dd25d2-8c40-453c-85cd-c8d57e2115d0 --><!-- begin field 9e675bea-e2fa-4bf0-80ba-97360dc80e37 --><ul><li>Discuss with people with suspected cancer (and their carers as appropriate, taking account of the need for confidentiality) their preferences for being involved in decision-making about referral options and further investigations including their potential risks and benefits.</li><li>Explain to people who are being referred with suspected cancer that they are being referred to a cancer service. Reassure them, as appropriate, that most people referred will not have a diagnosis of cancer, and discuss alternative diagnoses with them.</li><li>Give the person information on the possible diagnosis (both benign and malignant) in accordance with their wishes for information.</li><li>The information given to people with suspected cancer and their families and/or carers should cover, among other issues:<ul><li>Where the person is being referred to.</li><li>How long they will have to wait for the appointment.</li><li>How to obtain further information about the type of cancer suspected or help before the specialist appointment.</li><li>What to expect from the service the person will be attending.</li><li>What type of tests may be carried out, and what will happen during diagnostic procedures.</li><li>How long it will take to get a diagnosis or test results.</li><li>Whether they can take someone with them to the appointment.</li><li>Who to contact if they do not receive confirmation of an appointment.</li><li>Other sources of support.</li></ul></li><li>Provide information that is appropriate for the person in terms of language, ability, and culture, recognizing the potential for different cultural meanings associated with the possibility of cancer.</li><li>Have information available in a variety of formats on both local and national sources of information and support for people who are being referred with suspected cancer.</li><li>When referring a person with suspected cancer to a specialist service, assess their need for continuing support while waiting for their referral appointment. This should include inviting the person to contact their healthcare professional again if they have more concerns or questions before they see a specialist.</li><li>If the person has additional support needs because of their personal circumstances, inform the specialist (with the person's agreement).</li><li>When cancer is suspected in a child, discuss the referral decision and information to be given to the child with the parents or carers (and the child if appropriate).</li></ul><!-- end field 9e675bea-e2fa-4bf0-80ba-97360dc80e37 --><!-- end item 34dd25d2-8c40-453c-85cd-c8d57e2115d0 -->","subChapters":[{"id":"99a92b40-4b34-5e47-bb6b-941210cbc30e","slug":"basis-for-recommendation-eee","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 309e304a-194e-4c9a-9ecb-a2dd011b1ab3 --><h4>Basis for recommendation</h4><!-- end field 309e304a-194e-4c9a-9ecb-a2dd011b1ab3 -->","summary":null,"htmlStringContent":"<!-- begin item eee1455d-bb98-465e-8a31-16b6f426f6e8 --><!-- begin field c5009301-b374-4506-a357-56b0a5381346 --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/bone-soft-tissue-sarcoma-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field c5009301-b374-4506-a357-56b0a5381346 --><!-- end item eee1455d-bb98-465e-8a31-16b6f426f6e8 -->","subChapters":[]}]},{"id":"fbf17996-41a8-5744-b5ab-1865e1218f29","slug":"safety-netting","fullItemName":"Safety netting","depth":3,"htmlHeader":"<!-- begin field 29dd5bde-d06d-45e6-9cb9-f313919a18fd --><h3>Safety netting</h3><!-- end field 29dd5bde-d06d-45e6-9cb9-f313919a18fd -->","summary":null,"htmlStringContent":"<!-- begin item fe33d3e7-f4f6-4bf4-a9c5-50326acfe173 --><!-- begin field 065ac0cc-8b75-4d96-8717-ba6493e670db --><ul><li>Safety netting involves active monitoring of low risk people presenting with symptoms in primary care.</li><li>Explain to people who are being offered safety netting which symptoms to look out for and when they should return for re-evaluation. It may be appropriate to provide written information.</li><li>Reassure people in the safety netting group who are concerned that they may have cancer that with their current symptoms their risk of having cancer is low.</li><li>Ensure that the results of investigations are reviewed and acted upon appropriately, with the healthcare professional who ordered the investigation taking or explicitly passing on responsibility for this. Be aware of the possibility of false-negative results for chest X-rays and tests for occult blood in faeces.</li><li>Consider a review for people with any symptom that is associated with an increased risk of cancer, but who do not meet the criteria for referral or other investigative action. The review may be planned within a time frame agreed with the person or patient-initiated if new symptoms develop, the person continues to be concerned, or their symptoms recur, persist, or worsen.</li></ul><!-- end field 065ac0cc-8b75-4d96-8717-ba6493e670db --><!-- end item fe33d3e7-f4f6-4bf4-a9c5-50326acfe173 -->","subChapters":[{"id":"6e747456-0917-5f9a-b7a7-084001513034","slug":"basis-for-recommendation-013","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 2e32c8fc-3949-4bdf-a812-21f397a5b4d1 --><h4>Basis for recommendation</h4><!-- end field 2e32c8fc-3949-4bdf-a812-21f397a5b4d1 -->","summary":null,"htmlStringContent":"<!-- begin item 0134b294-2919-4291-ad84-49c167126d75 --><!-- begin field 328a94bd-eae3-4eb6-9e88-88d2ddbc954c --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/bone-soft-tissue-sarcoma-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 328a94bd-eae3-4eb6-9e88-88d2ddbc954c --><!-- end item 0134b294-2919-4291-ad84-49c167126d75 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}